University of Missouri
Columbia, Missouri, 65212, United States
NCT Number: NCT04051294
As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.
Looking for future studies?
Notify Me30 year–65 year
All sexes
Interventional
Not applicable
Columbia, Missouri, 65212, United States
Consumption of kombucha, a fermented tea beverage, has been promoted for a wide range of health benefits. However, a systematic literature review (Kapp & Sumner, 2019) revealed a lack of evidence for human health benefit. Despite the lack of evidence, U.S. retail sales of kombucha and other fermented beverages have increased 37.4% in 2017, and kombucha is the fastest growing product in the functional beverage market.
As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans. We plan for 20 subjects to take part in this study.
This is a randomized-controlled counter-balanced study design. Subjects will be asked to complete 4 in-person visits over 2 months time (twice per month). At the first visit, subjects will be randomized into one of four groups. At each subsequent visit, subjects will be randomized into one of the remaining groups until they have completed each arm.
Arms (at least 5 subjects in each arm, minimum total=20 subjects)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Commercially-available kombucha tea.
Kombucha tea brewed
Tea brewed in our lab.
Tap water
Time frame: Baseline
Blood drawn following a 10-12 hour fast.
Time frame: Baseline
Blood drawn following a 10-12 hour fast.
Time frame: 3 hour
Oral glucose tolerance test
Time frame: 3 hour
Oral glucose tolerance test
Time frame: Baseline
University of Missouri-Columbia
Other
A Clinical Trial to Measure the Biochemical Response of Kombucha Tea in Humans
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02642640
Circadian Rhythm, Genes
Boston, Massachusetts, United States
View Trial DetailsNCT07088497
Diabetes, Diabetes Mellitus
New Taipei City, Taiwan
View Trial DetailsNCT06704126
Blood Flow Restriction Therapy, Blood Flow Velocity
Lancaster, United Kingdom
View Trial DetailsNCT07031752
Caloric Intake, GLP-1 Concentration
Cáceres, Spain
View Trial Details